Concepedia

Jennifer Schumi

JS

8

Publications

678

Citations

8

H-Index

1998

Active since

Affiliations

AstraZeneca (United States)(Current)

University of Pennsylvania

Iowa State University

Williams College

University of California, Berkeley

Jennifer Schumi is an author at AstraZeneca (United States) specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1998–2022

8

Publications

8

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

Jean‐Claude Tardif, John J.V. McMurray, Eric Klug et al. · The Lancet · 2008 · 197 citations

, , +9

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Alette M. Wessels, Pierre N. Tariot, Jennifer A. Zimmer et al. · JAMA Neurology · 2019 · 191 citations · Full text

Prediction Intervals for Neural Networks via Nonlinear Regression

Richard D. De Veaux, Jennifer Schumi, Jason Schweinsberg et al. · Technometrics · 1998 · 175 citations

, , +11

Changes In Physician Supply And Scope Of Practice During A Malpractice Crisis: Evidence From Pennsylvania

Michelle M. Mello, David M. Studdert, Jennifer Schumi et al. · Health Affairs · 2007 · 28 citations

Prediction Intervals for Neural Networks via Nonlinear Regression

Richard D. De VlEAUX, Jennifer Schumi, Jason Schweinsberg et al. · Technometrics · 1998 · 28 citations

, , +11

Rows per page

1–5 of 8